CSLLY - Arcturus CSL win approval for world's first self-amplifying mRNA vaccine in Japan
2023-11-28 14:14:56 ET
More on Arcturus, CSL, etc.
- CSL Limited: Positive Capital Return And Earnings Growth Expectations
- From Financial Metrics To mRNA Milestones: Arcturus Therapeutics' Evolving Journey
- Arcturus: COVID Vaccine Approval Shots In Japan And Europe Key To Unlocking Upside
- Arcturus cystic fibrosis therapy gets orphan drug status
- Biggest stock movers today: Target, ZIM Integrated Shipping, JD.com, and more
For further details see:
Arcturus, CSL win approval for world’s first self-amplifying mRNA vaccine in Japan